4
Changes in Ownership
Protalix BioTherapeutics, Inc. Filed Acc 0001415889-25-021494
Director bought 129,000 shares at $1.60 ($205,884)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schwartz Aharon Director | 2025-06-10 | Purchase | +129,000 | $1.60 | $205,884 | 303,000 | D |
| Open-market purchases · 129,000 sh · avg $1.60 · $205,884 | |||||||
Loading xslF345X05/form4-08122025_040801.xml…